tradingkey.logo

ALX Oncology Holdings Inc <ALXO.OQ> expected to post a loss of 46 cents a share - Earnings Preview

ReutersMay 5, 2025 11:26 AM
  • ALX Oncology Holdings Inc ALXO.OQ ALXO.O is expected to show no change in quarterly revenue when it reports results on May 8 for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for ALX Oncology Holdings Inc is for a loss of 46 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for ALX Oncology Holdings Inc is $4.00​, above​ its last closing price of $0.53. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.62

-0.67

-0.55

Beat

17.9

Sep. 30 2024

-0.78

-0.78

-0.58

Beat

25.6

Jun. 30 2024

-0.77

-0.77

-0.76

Beat

1.7​

Mar. 31 2024

-0.85

-0.84

-0.71

Beat

15.1

​​Dec. 31 2023

-0.81

-0.84

-0.93

Missed

-10.5

Sep. 30 2023

-0.82

-0.87

-1.24

Missed

-42.5​

Jun. 30 2023

-0.88

-0.88

-0.84

Beat

4.5

Mar. 31 2023

-0.82

-0.80

-0.74

Beat

7.7

This summary was machine generated May 5 at 11:26 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI